Scarica l'app Stockscreener
0.5014
10.20%
0.0464
Dopo l'orario di chiusura:
.52
0.0186
+3.71%
Precedente Chiudi:
$0.455
Aprire:
$0.4402
Volume 24 ore:
2.11M
Relative Volume:
1.23
Capitalizzazione di mercato:
$19.67M
Reddito:
$3.04M
Utile/perdita netta:
$-33.97M
Rapporto P/E:
-0.377
EPS:
-1.33
Flusso di cassa netto:
$-52.47M
1 W Prestazione:
+20.27%
1M Prestazione:
+0.93%
6M Prestazione:
-66.57%
1 anno Prestazione:
-82.41%
Intervallo 1D:
$0.4402
$0.5046
Intervallo di 1 settimana:
$0.401
$0.5046
Portata 52W:
$0.387
$3.75
Rani Therapeutics Holdings Inc Stock (RANI) Company Profile
Nome
Rani Therapeutics Holdings Inc
Settore
Industria
Telefono
(408) 457-3700
Indirizzo
2051 RINGWOOD AVENUE, SAN JOSE
Confronta RANI con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
RANI
Rani Therapeutics Holdings Inc
|
0.5014 | 19.83M | 3.04M | -33.97M | -52.47M | -1.33 |
|
VRTX
Vertex Pharmaceuticals Inc
|
472.27 | 120.73B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.64 | 61.80B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
328.00 | 42.46B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
591.74 | 35.22B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
296.46 | 31.99B | 3.81B | -644.79M | -669.77M | -6.24 |
Rani Therapeutics Holdings Inc Stock (RANI) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-08-02 | Iniziato | Oppenheimer | Outperform |
| 2024-06-14 | Iniziato | Maxim Group | Buy |
| 2024-06-13 | Iniziato | Rodman & Renshaw | Buy |
| 2023-04-17 | Ripresa | BTIG Research | Buy |
| 2022-10-11 | Iniziato | UBS | Buy |
| 2022-07-27 | Iniziato | H.C. Wainwright | Buy |
| 2022-06-13 | Iniziato | Wedbush | Outperform |
Mostra tutto
Rani Therapeutics Holdings Inc Borsa (RANI) Ultime notizie
What analysts say about Rani Therapeutics Holdings Inc. stockTremendous growth potential - PrintWeekIndia
Rani Therapeutics Holdings Inc. Stock Analysis and ForecastFree Trend-Following Techniques - Autocar Professional
Is Rani Therapeutics Holdings Inc. a good long term investmentConsistent triple-digit returns - Autocar Professional
What drives Rani Therapeutics Holdings Inc. stock priceBreakthrough investment results - jammulinksnews.com
Why Rani Therapeutics Holdings Inc. stock attracts strong analyst attentionDaily Swing Candidates - Newser
Rani Therapeutics Announces New Securities Purchase Agreement - The Globe and Mail
Rani Therapeutics Shares Surge After ENDO 2025 Presentation Announcement - MSN
Rani Therapeutics stock plunges after $3 million registered direct offering By Investing.com - Investing.com India
Rani Therapeutics Shares Drop Sharply Following $3 Million Direct Offering Announcement - MSN
What makes Rani Therapeutics Holdings Inc. stock price move sharplyLong Term Low Risk Growth - Newser
Rani Therapeutics stock plunges after $3 million registered direct offering - Investing.com
How Rani Therapeutics Holdings Inc. stock performs during market volatility10x Return With Managed Risk - Newser
Rani Therapeutics secures $3 million through registered direct offering By Investing.com - Investing.com South Africa
Rani Therapeutics secures $3 million through registered direct offering - Investing.com
Rani Therapeutics Holdings, Inc. Announces Pricing of $3.0 Million Registered Direct Offering - The Manila Times
Rani Therapeutics Secures $3M Financing Deal: Biotech Firm Prices Shares at $0.40 in Strategic Offering - Stock Titan
Pre-market Movers: KAPA, CYCC, SONN, RANI... - RTTNews
Rani Therapeutics (NASDAQ:RANI) Shares Up 8.4% – Here’s What Happened - Defense World
The Psychology of Rani Therapeutics Holdings Inc Inc. (RANI) Price Performance: Understanding Market Sentiment - investchronicle.com
Rani Therapeutics stock soars after announcing ENDO 2025 presentation - Investing.com
Rani Therapeutics stock soars after announcing ENDO 2025 presentation By Investing.com - Investing.com Canada
Rani Therapeutics Surges on Game-Changing Oral Drug Delivery News - RagingBull
Why Datavault AI Shares Are Trading Higher By 7%; Here Are 20 Stocks Moving Premarket - Benzinga
Rani Therapeutics to Present Preclinical Data on RaniPill® Capsule at ENDO 2025 Conference - Nasdaq
Rani Therapeutics and ProGen Announce Late Breaking Presentation at ENDO 2025 Demonstrating Bioequivalence of Novel, Bispecific GLP-1/GLP-2 Receptor Agonist Delivered Orally via RaniPill Compared to Subcutaneous Delivery - GlobeNewswire
Revolutionary Oral GLP-1 Delivery System Matches Injectable Performance: RaniPill's Game-Changing Study Results - Stock Titan
Rani Therapeutics Holdings Inc Azioni (RANI) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.32%
1.57%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):